Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01924442 · ClinicalTrials.gov registry record

ROOBY Trial Follow-up Extension

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
2,203
Enrollment target

NCT01924442: Completed study, sponsored by VA Office of Research and Development.

NCT01924442 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,203 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01924442 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
2,203 participants
Enrollment target

Study Summary

The Department of Veterans Affairs "Randomized On/Off Bypass" (ROOBY) Trial (CSP #517) was funded in 2001. ROOBY was designed to compare the short-term (30-day) and intermediate-term (1-year) outcomes for patients undergoing off-pump versus on-pump coronary artery bypass graft (CABG) procedures. The ROOBY trial reported a significantly higher 1-year adverse composite outcome rate (i.e., all-cause death, non-fatal myocardial infarction (MI) and/or repeat revascularization) for off-pump versus on-pump patients. ROOBY documented that a higher percentage of off-pump patients received fewer grafts than originally planned (i.e., off-pump patients were less completely revascularized) as compared to on-pump patients. Across all anatomic regions of the heart, the 1-year graft patency rates were significantly lower for off-pump CABG patients. Based on these ROOBY trial initial findings, critically important clinical questions related to the long-term efficacy, stability and durability of the off-pump versus on-pump techniques have been raised. Extending the original ROOBY trial, this CSP #517 follow-up study (CSP 517-FS) will evaluate the longer-term impact of off-pump versus on-pump surgical approaches upon the future occurrence of major adverse cardiovascular events (MACE).

Primary Outcome

Five-year mortality was initially assessed by matching the participants in the follow-up study to data in the VA Vital Status File and the National Death Index, which provided cause-of-death codes according to the International Classification of Diseases, 10th Revision.

Trial Details

FieldValue
Enrollment Target 2,203 participants
Start Date 2013-10-01
Est. Completion 2018-09-30
VA Office of Research and Development

1,668 total trials

What the finished NCT01924442 record still lists

NCT01924442 is an observational study that tracks outcomes without assigning an intervention. Its 2,203 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01924442 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01924442 about?

NCT01924442 is a clinical study titled "ROOBY Trial Follow-up Extension". The Department of Veterans Affairs "Randomized On/Off Bypass" (ROOBY) Trial (CSP #517) was funded in 2001. ROOBY was designed to compare the short-term (30-day) and intermediate-term (1-year) outcomes for patients undergoing off-pump versus on-pump coronary artery bypass graft (CABG) procedures. The...

What is the current status of trial NCT01924442?

This trial is currently completed. The enrollment target is 2,203 participants. The study started on 2013-10-01. Estimated completion is 2018-09-30.

Who is sponsoring clinical trial NCT01924442?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05654207 · 2,200 participants · NA

    WeCare: A System of Care for Black Youth

  • NCT06144554 · 2,200 participants

    Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

  • NCT06526988 · 2,200 participants · NA

    Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

  • NCT06682650 · 2,200 participants · NA

    Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01924442, the US trial registry maintained by the National Library of Medicine. NCT01924442 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.